Intellia Therapeutics Insider Trades
NASDAQ: NTLAHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 1 · $1.40M
- Sales
- 19 · $2.27M
- Shares bought / sold
- 150.00K / 222.77K
- Net activity
- Net selling $868,724
Intellia Therapeutics insider activity
Over the last 12 months, Intellia Therapeutics insiders reported 37 transactions on SEC Form 4: 1 open-market purchase and 19 sales. Insiders bought $1.4 million and sold $2.3 million worth of stock, for net insider selling of $868,724. The largest seller was LEONARD JOHN M, with $1.5 million in reported sales.
The most recent filing shows LEONARD JOHN M (President and CEO) selling 9,000 shares at $11.99 on Nov 2, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put NTLA's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
NTLA insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Nov 2, 2026 | LEONARD JOHN MPresident and CEO | Sale | 9,000 | $107.91K | Form 4 |
| Oct 26, 2026 | Marantz Jing L.EVP, Chief Medical Officer | Award | 199,822 | — | Form 4 |
| Oct 2, 2026 | Dube Michael PVP, Chief Accounting Officer | Sale | 1,864 | $23.17K | Form 4 |
| Aug 21, 2026 | LEONARD JOHN MPresident and CEO | Sale | 2,785 | $36.20K | Form 4 |
| Aug 20, 2026 | LEONARD JOHN MPresident and CEO | Sale | 19,890 | $250.61K | Form 4 |
| Jul 22, 2026 | Dulac Edward J IIIEVP, Chief Financial Officer | Sale | 8,111 | $91.25K | Form 4 |
| Jul 2, 2026 | Dulac Edward J IIIEVP, Chief Financial Officer | Sale | 4,677 | $84.19K | Form 4 |
| Jul 1, 2026 | Dube Michael PVP, Chief Accounting Officer | Sale | 2,641 | $44.32K | Form 4 |
| Jun 9, 2026 | CHASE WILLIAM JDirector | Award | 9,200 | — | Form 4 |
| Jun 9, 2026 | Cohen Fred EDirector | Award | 9,200 | — | Form 4 |
| Jun 9, 2026 | GOODMAN JESSEDirector | Award | 9,200 | — | Form 4 |
| Jun 9, 2026 | Bhanji MunaDirector | Award | 9,200 | — | Form 4 |
| Jun 9, 2026 | Keresty GeorgiaDirector | Award | 9,200 | — | Form 4 |
| Jun 9, 2026 | Verwiel FrankDirector | Award | 9,200 | — | Form 4 |
| Jun 9, 2026 | Goff BrianDirector | Award | 9,200 | — | Form 4 |
| Mar 2, 2026 | Clark ElianaEVP, Chief Technical Officer | Sale | 607 | $8.36K | Form 4 |
| Mar 2, 2026 | BASTA JAMESEVP, General Counsel | Sale | 1,211 | $16.69K | Form 4 |
| Mar 1, 2026 | Dube Michael PVP, Chief Accounting Officer | Award | 17,250 | — | Form 4 |
| Mar 1, 2026 | Dulac Edward J IIIEVP, Chief Financial Officer | Award | 61,280 | — | Form 4 |
| Mar 1, 2026 | Clark ElianaEVP, Chief Technical Officer | Award | 7,353 | — | Form 4 |
| Mar 1, 2026 | Schultes Birgit CEVP, Chief Scientific Officer | Award | 39,200 | — | Form 4 |
| Mar 1, 2026 | Lebwohl DavidEVP, Chief Medical Officer | Award | 9,943 | — | Form 4 |
| Mar 1, 2026 | BASTA JAMESEVP, General Counsel | Award | 46,080 | — | Form 4 |
| Mar 1, 2026 | LEONARD JOHN MPresident and CEO | Award | 156,400 | — | Form 4 |
| Jan 5, 2026 | Dulac Edward J IIIEVP, Chief Financial Officer | Sale | 6,379 | $58.75K | Form 4 |
| Jan 5, 2026 | Clark ElianaEVP, Chief Technical Officer | Sale | 9,515 | $87.63K | Form 4 |
| Jan 5, 2026 | BASTA JAMESEVP, General Counsel | Sale | 10,397 | $95.76K | Form 4 |
| Jan 5, 2026 | Dube Michael PVP, Chief Accounting Officer | Sale | 2,989 | $27.53K | Form 4 |
| Jan 5, 2026 | Lebwohl DavidEVP, Chief Medical Officer | Sale | 11,903 | $109.63K | Form 4 |
| Jan 5, 2026 | Cohen Fred EDirector | Buy | 150,000 | $1.40M | Form 4 |
| Jan 5, 2026 | Schultes Birgit CEVP, Chief Scientific Officer | Sale | 8,508 | $78.36K | Form 4 |
| Jan 5, 2026 | LEONARD JOHN MPresident and CEO | Sale | 34,146 | $314.48K | Form 4 |
| Dec 12, 2025 | LEONARD JOHN MPresident and CEO | Option exercise | 8,557 | $58.44K | Form 4 |
| Dec 11, 2025 | LEONARD JOHN MPresident and CEO | Sale | 5,355 | $51.35K | Form 4 |
| Dec 11, 2025 | LEONARD JOHN MPresident and CEO | Sale | 32,832 | $310.92K | Form 4 |
| Dec 11, 2025 | LEONARD JOHN MPresident and CEO | Sale | 49,959 | $474.11K | Form 4 |
| Dec 11, 2025 | LEONARD JOHN MPresident and CEO | Option exercise | 49,959 | $341.22K | Form 4 |
| Oct 1, 2025 | Dube Michael PVP, Chief Accounting Officer | Sale | 1,871 | $32.52K | Form 4 |
| Oct 1, 2025 | Schultes Birgit CEVP, Chief Scientific Officer | Sale | 31 | $538.78 | Form 4 |
| Aug 20, 2025 | CHASE WILLIAM JDirector | Buy | 100,000 | $1.00M | Form 4 |
| Jul 23, 2025 | Dulac Edward J IIIEVP, Chief Financial Officer | Sale | 7,462 | $104.62K | Form 4 |
| Jul 2, 2025 | Dube Michael PVP, Chief Accounting Officer | Sale | 2,503 | $24.90K | Form 4 |
| Jul 1, 2025 | GOODMAN JESSEDirector | Sale | 1,547 | $14.28K | Form 4 |
| Jul 1, 2025 | Clark ElianaEVP, Chief Technical Officer | Sale | 1,022 | $10.04K | Form 4 |
| Jun 30, 2025 | GOODMAN JESSEDirector | Sale | 1,547 | $14.79K | Form 4 |
| Jun 11, 2025 | Bhanji MunaDirector | Award | 8,000 | — | Form 4 |
| Jun 11, 2025 | Goff BrianDirector | Award | 8,000 | — | Form 4 |
| Jun 11, 2025 | GOODMAN JESSEDirector | Award | 8,000 | — | Form 4 |
| Jun 11, 2025 | Verwiel FrankDirector | Award | 8,000 | — | Form 4 |
| Jun 11, 2025 | Keresty GeorgiaDirector | Award | 8,000 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4